VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $808,860 | +102.2% | 34,000 | +74.2% | 0.09% | +66.7% |
| Q3 2022 | $400,000 | -95.9% | 19,518 | -97.7% | 0.05% | -96.4% |
| Q2 2022 | $9,731,000 | +484.8% | 841,018 | +834.5% | 1.52% | +606.0% |
| Q1 2022 | $1,664,000 | -6.5% | 90,000 | 0.0% | 0.22% | +20.8% |
| Q4 2021 | $1,779,000 | +57.3% | 90,000 | +33.0% | 0.18% | -12.7% |
| Q1 2021 | $1,131,000 | – | 67,685 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
| TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
| VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
| Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
| Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
| Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
| Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
| Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
| Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |